Literature DB >> 26443816

Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA.

Frieder Schaumburg1, Georg Peters2, Abraham Alabi3, Karsten Becker2, Evgeny A Idelevich2.   

Abstract

OBJECTIVES: Ceftaroline and ceftobiprole are new cephalosporins, which are active against MRSA by inhibiting PBP2a. Recently, high rates of resistance to ceftaroline were reported from Ghana. The objective of this study was to assess rates of resistance to ceftaroline and ceftobiprole in MRSA from Africa and to describe potential missense mutations of PBP2a.
METHODS: MRSA isolates derived from Staphylococcus aureus colonization (n = 37) and infection (n = 23) and were collected in Côte d'Ivoire (n = 17), DR Congo (n = 6), Gabon (n = 21) and Nigeria (n = 16). The MICs were determined by the broth microdilution method. The mecA gene was sequenced and missense mutations were associated with the corresponding MLST ST.
RESULTS: In total, 16.7% (n = 10) and 15% (n = 9) of isolates were resistant to ceftaroline and ceftobiprole, respectively. The corresponding MICs of ceftaroline and ceftobiprole correlated significantly (r = 0.92). Isolates belonging to ST241 harboured a triple mutation of PBP2a (N146K-N204K-G246E), which was associated with high rates of resistance to ceftaroline (90.9%) and ceftobiprole (81.8%).
CONCLUSIONS: Resistances to ceftaroline and ceftobiprole were only detected in Nigeria and were associated with ST241 and a triple mutation of PBP2a.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26443816     DOI: 10.1093/jac/dkv325

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

1.  Ceftaroline Resistance by Clone-Specific Polymorphism in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus.

Authors:  Hyukmin Lee; Eun-Jeong Yoon; Dokyun Kim; Jung Wook Kim; Kwang-Jun Lee; Hyun Soo Kim; Young Ree Kim; Jong Hee Shin; Jeong Hwan Shin; Kyeong Seob Shin; Young Ah Kim; Young Uh; Seok Hoon Jeong
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

2.  High Rate of Ceftobiprole Resistance among Clinical Methicillin-Resistant Staphylococcus aureus Isolates from a Hospital in Central Italy.

Authors:  Gianluca Morroni; Andrea Brenciani; Lucia Brescini; Simona Fioriti; Serena Simoni; Antonella Pocognoli; Marina Mingoia; Eleonora Giovanetti; Francesco Barchiesi; Andrea Giacometti; Oscar Cirioni
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

3.  The Recombinant Bacteriophage Endolysin HY-133 Exhibits In Vitro Activity against Different African Clonal Lineages of the Staphylococcus aureus Complex, Including Staphylococcus schweitzeri.

Authors:  Evgeny A Idelevich; Frieder Schaumburg; Dennis Knaack; Anna S Scherzinger; Wolfgang Mutter; Georg Peters; Andreas Peschel; Karsten Becker
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 4.  Antimicrobial resistance in methicillin-resistant Staphylococcus aureus to newer antimicrobial agents.

Authors:  Richard R Watkins; Marisa Holubar; Michael Z David
Journal:  Antimicrob Agents Chemother       Date:  2019-09-16       Impact factor: 5.191

5.  Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals.

Authors:  D O Andrey; P François; C Manzano; E J Bonetti; S Harbarth; J Schrenzel; W L Kelley; A Renzoni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-15       Impact factor: 3.267

6.  Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.

Authors:  Lee-Chung Lin; Shih-Cheng Chang; Mao-Cheng Ge; Tsui-Ping Liu; Jang-Jih Lu
Journal:  Infect Drug Resist       Date:  2018-01-18       Impact factor: 4.003

7.  Plasmid-Encoded Transferable mecB-Mediated Methicillin Resistance in Staphylococcus aureus.

Authors:  Karsten Becker; Sarah van Alen; Evgeny A Idelevich; Nina Schleimer; Jochen Seggewiß; Alexander Mellmann; Ursula Kaspar; Georg Peters
Journal:  Emerg Infect Dis       Date:  2018-02       Impact factor: 6.883

8.  In Vitro Activity of the Bacteriophage Endolysin HY-133 against Staphylococcus aureus Small-Colony Variants and Their Corresponding Wild Types.

Authors:  Nina Schleimer; Ursula Kaspar; Dennis Knaack; Christof von Eiff; Sonja Molinaro; Holger Grallert; Evgeny A Idelevich; Karsten Becker
Journal:  Int J Mol Sci       Date:  2019-02-07       Impact factor: 5.923

Review 9.  Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms.

Authors:  Despoina Koulenti; Elena Xu; Isaac Yin Sum Mok; Andrew Song; Drosos E Karageorgopoulos; Apostolos Armaganidis; Jeffrey Lipman; Sotirios Tsiodras
Journal:  Microorganisms       Date:  2019-08-18

10.  Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSA.

Authors:  Maria Celeste Varela; Melanie Roch; Agustina Taglialegna; Scott W Long; Matthew Ojeda Saavedra; Warren E Rose; James J Davis; Lucas R Hoffman; Rafael E Hernandez; Roberto R Rosato; Adriana E Rosato
Journal:  Commun Biol       Date:  2020-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.